Skip to main content
construction release_alert
Profile editing is temporarily unavailable from June 11-24, 2026 while manual profile data entry transitions to Elements. Learn More.
cancel
Journal cover image

Study design and methodologies for the men moving forward lifestyle intervention trial with black prostate cancer survivors.

Publication ,  Journal Article
Awoyinka, I; Sheean, P; Papanek, P; Flynn, KE; Bylow, K; Kilari, D; Gann, P; Banerjee, A; Stolley, M
Published in: Contemp Clin Trials
February 2026

BACKGOUND: Prostate cancer (PC) incidence and mortality rates are significantly higher among Black/African-American (Black) men compared to men of other race/ethnicities. Comorbidities and compromised quality of life are also greater challenges for this community of men. Many factors drive these differences among which body composition and health behaviors are important, yet modifiable contributors. Lifestyle interventions report beneficial results for PC survivors; however, the inclusion of Black men is critically limited. This paper describes Men Moving Forward (MMF) -a community-based lifestyle intervention for Black men with PC. METHODS/DESIGN: This trial will randomize (1:1) 200 Black men with PC who completed treatment or are on active surveillance. The 16-week MMF intervention, conducted in partnership with the Milwaukee Recreation system, supports adoption of the American Cancer Society Nutrition and Physical Activity guidelines. Measures of body composition (primary), behavior (diet, physical activity), fitness, quality of life, and biomarkers of general health and PC recurrence risk are collected at baseline, post-intervention and at a 12-month follow-up. The primary hypothesis is that men receiving the MMF intervention will exhibit greater changes in body composition than those in the wait-list control group. DISCUSSION: The MMF trial addresses an important gap in the current literature, evaluating the potential efficacy of a lifestyle program developed with and for Black men with PC. Outcomes including body composition and biomarkers of general health and PC recurrence risk add to our knowledge and methodologies on health behaviors and PC survivorship. Study results will inform survivorship efforts for this high-risk, underrepresented population. U.S. CLINICALTRIALS: gov number: NCT03971591, 06.01.2019.

Duke Scholars

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

February 2026

Volume

161

Start / End Page

108205

Location

United States

Related Subject Headings

  • White
  • Research Design
  • Randomized Controlled Trials as Topic
  • Quality of Life
  • Public Health
  • Prostatic Neoplasms
  • Middle Aged
  • Male
  • Life Style
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Awoyinka, I., Sheean, P., Papanek, P., Flynn, K. E., Bylow, K., Kilari, D., … Stolley, M. (2026). Study design and methodologies for the men moving forward lifestyle intervention trial with black prostate cancer survivors. Contemp Clin Trials, 161, 108205. https://doi.org/10.1016/j.cct.2025.108205
Awoyinka, Iwalola, Patricia Sheean, Paula Papanek, Kathryn E. Flynn, Kathryn Bylow, Deepak Kilari, Peter Gann, Anjishnu Banerjee, and Melinda Stolley. “Study design and methodologies for the men moving forward lifestyle intervention trial with black prostate cancer survivors.Contemp Clin Trials 161 (February 2026): 108205. https://doi.org/10.1016/j.cct.2025.108205.
Awoyinka I, Sheean P, Papanek P, Flynn KE, Bylow K, Kilari D, et al. Study design and methodologies for the men moving forward lifestyle intervention trial with black prostate cancer survivors. Contemp Clin Trials. 2026 Feb;161:108205.
Awoyinka, Iwalola, et al. “Study design and methodologies for the men moving forward lifestyle intervention trial with black prostate cancer survivors.Contemp Clin Trials, vol. 161, Feb. 2026, p. 108205. Pubmed, doi:10.1016/j.cct.2025.108205.
Awoyinka I, Sheean P, Papanek P, Flynn KE, Bylow K, Kilari D, Gann P, Banerjee A, Stolley M. Study design and methodologies for the men moving forward lifestyle intervention trial with black prostate cancer survivors. Contemp Clin Trials. 2026 Feb;161:108205.
Journal cover image

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

February 2026

Volume

161

Start / End Page

108205

Location

United States

Related Subject Headings

  • White
  • Research Design
  • Randomized Controlled Trials as Topic
  • Quality of Life
  • Public Health
  • Prostatic Neoplasms
  • Middle Aged
  • Male
  • Life Style
  • Humans